首页 | 本学科首页   官方微博 | 高级检索  
     


Tick salivary secretion as a source of antihemostatics
Authors:Chmelar Jindrich  Calvo Eric  Pedra Joao H F  Francischetti Ivo M B  Kotsyfakis Michail
Affiliation:Division of Vascular Inflammation, Diabetes and Kidney, Department of Medicine and Institute of Physiology, Technical University Dresden, 01307 Dresden, Germany.
Abstract:Ticks are mostly obligatory blood feeding ectoparasites that have an impact on human and animal health. In addition to direct damage due to feeding, some tick species serve as the vectors for the causative agents of several diseases, such as the spirochetes of the genus Borrelia causing Lyme disease, the virus of tick-borne encephalitis, various Rickettsial pathogens or even protozoan parasites like Babesia spp. Hard ticks are unique among bloodfeeders because of their prolonged feeding period that may last up to two weeks. During such a long period of blood uptake, the host develops a wide range of mechanisms to prevent blood loss. The arthropod ectoparasite, in turn, secretes saliva in the sites of bite that assists blood feeding. Indeed, tick saliva represents a rich source of proteins with potent pharmacologic action that target different mechanisms of coagulation, platelet aggregation and vasoconstriction. Tick adaptation to their vertebrate hosts led to the inclusion of a powerful protein armamentarium in their salivary secretion that has been investigated by high-throughput methods. The resulting knowledge can be exploited for the isolation of novel antihemostatic agents. Here we review the tick salivary antihemostatics and their characterized functions at the molecular and cellular levels.
Keywords:aPTT, activated partial thromboplastin time   BmGTI, Boophilus microplus gut thrombin inhibitor   BmTI-A, Boophilus microplus trypsin inhibitor-A   BPTI, bovine pancreatic trypsin inhibitor   BTSP, basic tail‐secreted proteins   FIX, coagulation factor IX   fMLP, formyl-methionyl-leucyl-proline   FV, coagulation factor V   FVII, coagulation factor VII   FVIIa, activated coagulation factor VII   FVIII, coagulation factor VIII   FX, coagulation factor X   FXa, activated coagulation factor X   FXI, coagulation factor XI   FXII, coagulation factor XII   HBP, histamine‐binding protein   HRF, histamine‐releasing factor   Ir-CPI, Ixodes ricinus contact phase inhibitor   IRIS, Ixodes ricinus immunosuppressant   IRS-2, Ixodes ricinus serpin-2   NR, non reduntant   NTI, nymphal thrombin inhibitor   PAF, platelet aggregation factor   PAR, protease-activated receptor   PGE2, prostaglandin E2   PGs, prostaglandins G   PT, prothrombin time   RGD motif, arginine-glycine-aspartate motif   RSL, reactive site loop   Salp14, salivary protein 14   SGE, salivary gland extract   SGs, salivary glands   TAI, tick adhesion inhibitor   TAP, tick anticoagulant protein   TF, tissue factor   TFPI, tissue factor pathway inhibitor   TSGP, tick salivary gland protein   TT, thrombin time   TXA2, thromboxane A2   Xase, tenase complex
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号